2.36
Immunitybio Inc 주식(IBRX)의 최신 뉴스
Will ImmunityBio Inc. rebound enough to break evenJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pick2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
Will ImmunityBio Inc. stock outperform tech sector in 2025Quarterly Performance Summary & Precise Swing Trade Alerts - newser.com
How ImmunityBio Inc. stock reacts to job market data2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm
ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Short interest data insights for ImmunityBio Inc.Earnings Growth Report & Technical Pattern Recognition Alerts - newser.com
Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
What MACD and RSI say about ImmunityBio Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
ImmunityBio (IBRX): Revisiting Valuation After ANKTIVA’s Regulatory Wins and New Growth Initiatives - Sahm
How high can ImmunityBio Inc. stock go2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Wall Street Bullish on ImmunityBio (IBRX) Since the Announcement of New Findings From QUILT-3.055 Study - MSN
ImmunityBio’s (IBRX) ANKTIVA Shows Survival Gains in Lung Cancer Patients - MSN
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - Insider Monkey
What drives ImmunityBio Inc stock priceStock Liquidity Analysis & Free Trend Following Techniques - earlytimes.in
자본화:
|
볼륨(24시간):